Together, these results suggest that TAOK3 regulates a critical node governing hepatocellular lipid homeostasis and that TAOK3 antagonism could mitigate NAFLD initiation as well as disease progression toward NASH. The gene discussed is TAOK3; the disease is metabolic dysfunction-associated steatotic liver disease.